NCT02854748View on ClinicalTrials.gov

Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

Empagliflozin 25mg

Empagliflozin 25 mg QD for 5 days

DRUG

Lobeglitazone 0.5mg

Lobeglitazone 0.5mg QD for 5 days

DRUG

Empagliflozin 25mg/Lobeglitazone 0.5mg

Empagliflozin 25 mg + Lobeglitazone 0.5mg QD for 5 days

Trial Locations (1)

49201

Dong A University Hospital, Seo-gu

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY